Konzernchef Mike Doustdar beziffert den Anteil am Markt für orale Abnehmmittel auf 90 Prozent. #Pharmaaktien #Abnehmmedikamente #Marktanalyse
Abnehmpillen: Milliardenmarkt lockt Pharma-Anleger
kurier.at
The market for weight loss medications is expected to grow to 190 billion dollars by 2035, with Eli Lilly considered the market leader, while Novo Nordisk is fighting for a comeback and investors are interested in a broader approach to pharmaceutical stocks that goes beyond just weight loss. #Pharmaaktien #Abnehmmedikamente #Marktanalyse (translated)
Abnehmpillen: Milliardenmarkt lockt Pharma-Anleger
